Grid Therapeutics Signs Exclusive License to Develop a Novel Immuno-Oncology Antibody Posted on August 28, 2017, in News, Press Releases wp_link_pages( array( 'before' => ' ' . esc_html__( 'Pages:', 'gridtherapeutics' ), 'after' => ' ', ) ); ?> Read more